BioSpace News Archive

Deals

Aptose Announces Pricing of Public Offering of Common Shares - July 16, 2020

Aptose Biosciences Inc., announced that it priced its previously announced underwritten public offering of 10,500,000 common shares at a public offering price of US$5.25 per share.

July 15, 2020
·
5 min read
BioMidwest

Institute for Supply Management® Expands Portfolio of Economic Reports with Launch of Hospital PMI™

ISM® Introduces Hospital PMI™ and Renames Non-Manufacturing Index (NMI®) as Services PMI™

July 15, 2020
·
4 min read
Pharm Country

Olympus Spiration® Valve System Earns Silver 2020 Edison Award

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced its Spiration® Valve System won Silver in the Medical category of the 2020 Edison Awards™.

July 15, 2020
·
3 min read
Pharm Country

States Slow to Implement Stay-at-Home Orders Saw Higher Rates of COVID-19 Deaths

Researchers from Children’s Hospital of Philadelphia and University of Pennsylvania estimate the efficacy of social distancing

July 15, 2020
·
3 min read
Drug Development

VALBIOTIS Announces the First Patient First Visit in the International Phase II/III REVERSE-IT Clinical Study on TOTUM-63 to Reduce Type 2 Diabetes Risk Factors

VALBIOTIS (Paris:ALVAL) (FR0013254851 - ALVAL, PEA/SME eligible) a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the First Patient First Visit in the international Phase II/III REVERSE-IT clinical study designed to assess TOTUM-63 for the reduction of Type 2 Diabetes metabolic risk factors.

July 15, 2020
·
7 min read
Pharm Country

Vivasc Therapeutics Inc. Receives NIH Phase I STTR Grant to Utilize Novel Cardiac Targeting Peptides for Targeted Delivery of Amiodarone to the Heart for Treatment of Atrial Fibrillation

The University of Pittsburgh and Vivasc Therapeutics Inc. today announced a research grant awarded by the NIH National Heart, Lung, and Blood Institute, valued at approximately $327,000 for the continued development of CTP-amio, the company’s lead compound, for the treatment of arrhythmias.

July 15, 2020
·
1 min read
Biotech Bay

Stem Cells for Everyone: Revolutionizing Regenerative Medicine with Mass Manufacturing of Induced Pluripotent Stem Cells (iPSCs)

I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-wining technology of induced pluripotent stem cells (iPSCs) has successfully developed a novel system to mass manufacture clinical-grade iPSCs for cell therapy in a palm-size closed cassette

July 15, 2020
·
7 min read
BioMidwest

Riverview Health Emergency Room & Urgent Care Opens Its Second Combined ER and Urgent Care Facility in the Indianapolis Area

The New Facility Will Offer Convenient, Quick Access to Quality Emergency Room and Urgent Care in Hamilton County

July 15, 2020
·
4 min read
Business

TI Health and Medisafe Partner to Extend 1st Party Patient Targeting Solutions

Data-driven healthcare marketing leader TI Health has entered into a partnership with Medisafe, to further build out education and awareness opportunities for unique hand-raising patient targeting solutions for pharmaceutical companies.

July 15, 2020
·
2 min read
BioMidwest

Battelle’s CCDS Critical Care Decontamination System™ Does Not Affect Filtration Performance of Tested N95 Filtering Facepiece Respirators through 20 Cycles According to Study by Leading Respirator Manufacturer

The Battelle CCDS Critical Care Decontamination System™ (CCDS) passed both filtration efficiency and fit-related evaluations through 20 cycles for two different 3M respirators tested (models 1860 and 8210), with results published in 3M’s latest technical bulletin

July 15, 2020
·
3 min read